Number of items: 5.
2024
Cleland, J. et al.
(2024)
The IRONMAN trial of intravenous iron for heart failure. Adjudication of hospitalizations and deaths.
Journal of the American College of Cardiology,
(Accepted for Publication)
Cleland, J. G.F. et al.
(2024)
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
European Heart Journal, 45(16),
pp. 1410-1426.
(doi: 10.1093/eurheartj/ehae086)
(PMID:38446126)
(PMCID:PMC11032711)
2022
Kalra, P. R. et al.
(2022)
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
Lancet, 400(10369),
pp. 2199-2209.
(doi: 10.1016/S0140-6736(22)02083-9)
(PMID:36347265)
Kalra, P. R. et al.
(2022)
Rationale and design of a randomised trial of intravenous iron in patients with heart failure.
Heart, 108(24),
pp. 1979-1985.
(doi: 10.1136/heartjnl-2022-321304)
(PMID:35948408)
(PMCID:PMC9726969)
2015
Mccowan, C. , Thomson, E., Szmigielski, C. A., Kalra, D., Sullivan, F. M., Prokosch, H.-U., Dugas, M. and Ford, I.
(2015)
Using electronic health records to support clinical trials: a report on stakeholder engagement for EHR4CR.
BioMed Research International, 2015,
707891.
(doi: 10.1155/2015/707891)
(PMID:26539523)
(PMCID:PMC4619877)
This list was generated on Fri Dec 6 08:45:37 2024 GMT.